Viewing Study NCT03117361


Ignite Creation Date: 2025-12-24 @ 12:45 PM
Ignite Modification Date: 2026-01-10 @ 1:35 PM
Study NCT ID: NCT03117361
Status: TERMINATED
Last Update Posted: 2020-12-02
First Post: 2017-04-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of Plitidepsin (AplidinĀ®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide
Sponsor: PharmaMar
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None multiple myeloma View
None plitidepsin View
None Aplidin View